Analysis of Blood Alcohol by Headspace with Simultaneous GC-FID and MS Detection

Importance of the Topic

Blood alcohol concentration (BAC) analysis is a critical component in forensic laboratories for legal and safety applications. The accuracy and reliability of BAC measurements have direct consequences in criminal investigations and roadside testing.

Objectives and Study Overview

This study evaluates the performance of simultaneous gas chromatography–flame ionization detection (GC-FID) and mass spectrometry (MS) for blood alcohol analysis. By integrating compound identification via spectral matching with quantitative confirmation from FID, the method aims to enhance confidence in BAC reporting.

Methodology and Instrumentation

Sample Preparation:

• Calibration standards of methanol, ethanol, isopropanol, and acetone at 0.01–0.4 g/dL; internal standard n-propanol at 0.05 g/dL.
• Control standard prepared similarly for precision testing.

Instrument Configuration:

• Headspace Inlet: Shimadzu HS-20, static loop, 1 mL sample, 65 °C equilibration, 15 min, split 20:1.
• GC System: Shimadzu GC-2010 Plus, isothermal at 40 °C, Rtx-BAC1 capillary columns (30 m × 0.32 mm × 1.8 µm), He carrier gas, 5 min run.
• Detection: Parallel FID (240 °C) and GCMS-QP2010 SE in scan mode (30–150 m/z), EI 70 eV, MS interface at 200 °C.

Key Results and Discussion

Retention Times:
Simultaneous analysis produced distinct RTs on FID and MS due to pressure differences; identification unaffected by calibration on each detector.
Compound Confirmation:
Mass spectra of ethanol matched NIST library entries with >98% similarity for unequivocal identification.
Calibration and Linearity:
Four-point curves for ethanol showed R2≥0.9998 on both detectors over 0.01–0.4 g/dL.
Precision:
Six replicates at 0.05 g/dL yielded RSDs <2% for all analytes across both detectors.

Benefits and Practical Applications

• Enhanced specificity through dual detection and mass spectral confirmation.
• Rapid throughput with 6 min total cycle time.
• Robust quantitative performance suitable for forensic casework and clinical settings.

Future Trends and Possibilities

Advances may include high-resolution or time-of-flight MS for greater selectivity, integrated software for automated data review, miniaturized headspace systems for field use, and expanded spectral libraries for emerging intoxicants.

Conclusion

Combining GC-FID with MS in a parallel configuration delivers precise quantification and definitive compound identification for blood alcohol analysis. The method meets forensic accuracy requirements with high linearity, precision, and confirmation capability across relevant concentration ranges.